The tools function in any type of study requirement — from simple to complex — out of the box or customised to the customer’s process.
The customer can select which tools are appropriate for their needs and the tools can also be used anytime, anywhere, and by multiple users during the setup and conduct of the trial.
Mark Penniston, Executive Vice President, Clinical Analytics and General Manager at Chiltern, said: “Our partnership with Medidata and its industry-leading platform aligns with our strategy providing an exceptional customer experience around best-in-class technologies.
"Currently our Data & Analysis team leads the field in providing the latest platforms and technologies and the Medidata Rave Value Accelerators support our stronghold in the technology space.”
Included are three accelerator tools: the Chiltern EC Reviewer for Medidata Rave, Chiltern EC Detector for Medidata Rave and Chiltern EC Analyzer for Medidata Rave.
The accelerator tools are designed to create flexibility for users, helping them accommodate their workflow environments, and are scalable from one study to hundreds and from Phase I to global Phase IV studies.